Army 15.1 sbir topic DHA funded sbir 2ND phase II medical r & d contract for proposal #H2-0475, titled: "next-generation adenovirus vaccine" erms 19151002
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH19C0169
- Awardee
-
Technovax Inc. UEI CQC1WKNLJC41
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $2,574,853
Award facts
- Opportunity
-
- HQ003419R1ADB Solicitation number
- Contract value 100% obligated
- $2,574,853.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Elmsford, NY, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $1,500,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,074,853 |
About this award
This is a $2,574,853.28 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Technovax Inc., a Minority Owned, Self Certified Small Disadvantaged Business, for the "Next-Generation Adenovirus Vaccine" under the ARMY 15.1 SBIR (Small Business Innovation Research) program. The contract is set aside for Small Businesses and has a period of performance through March 31, 2023. The contract is associated with the National Interest Action Code for the Coronavirus COVID-19 pandemic, indicating this research and development effort is related to medical countermeasures. As an SBIR Phase II contract, this represents a follow-on award to further develop the proposed vaccine technology.
Quick answers
Who was awarded contract W81XWH19C0169?
W81XWH19C0169 was awarded to Technovax Inc. by Medical Command (Department of the Army) on September 16, 2019.
How much is contract W81XWH19C0169 worth?
The government has obligated $2,574,853 on W81XWH19C0169.
Was contract W81XWH19C0169 competed?
The extent of competition for W81XWH19C0169 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award